InvestorsHub Logo
Followers 29
Posts 1597
Boards Moderated 0
Alias Born 12/16/2012

Re: walltr8der post# 9056

Tuesday, 06/04/2019 10:15:28 AM

Tuesday, June 04, 2019 10:15:28 AM

Post# of 11429
The details of the transaction were disclosed this morning via an 8-K filed with the SEC.

BWR did 21M in 2018 annual revenue.
NBEV paid 700,000 NBEV shares in consideration for the company.
(This amount of shares could be reduced, and adjusted lower based upon a final working capital adjustment, at closing).

The deal also includes 500K in cash consideration to the seller, plus up to 2.5M in cash that can only be used towards eliminating all debt in BWR.

BWR will be debt free and cash free at closing.


I’d say it was the uncertainty from the FDA, combined with a weak MJ market, combined with very jittery broad market, combined with the huge short interest. When we broke $5 yesterday it certainly triggered many stop losses.

Also, while good news, it wasn’t quite the news shareholders were looking for.
The market wanted to hear more about Docklight/CBD/CBD Bevs/Japan/Aeon/Coke, etc..

In my opinion

Everything I say is only my opinion, and should not be construed or relied upon as investment advice.